Johnson and Johnson Stock Price

-4.24 (-2.96%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Johnson and Johnson JNJ NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-4.24 -2.96% 138.91 19:01:51
Close Price Low Price High Price Open Price Previous Close
138.36 138.18 141.98 141.09 143.15
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
103,848 8,424,721 $ 139.21 $ 1,172,834,981 6,203,422 109.16 - 157.00
Last Trade Time Type Quantity Stock Price Currency
19:00:29 10 $ 138.97 USD

Johnson and Johnson Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 363.95B 2.63B 2.63B $ 82.06B $ 17.34B 5.63 22.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
11.45M $ 3.75 2.71% - -

more financials information »

Johnson and Johnson News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JNJ Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week144.10147.47138.18144.245,264,906-5.19-3.6%
1 Month147.53153.142138.18147.106,072,283-8.62-5.84%
3 Months149.32155.47138.18148.375,943,446-10.41-6.97%
6 Months152.16155.47137.02147.016,543,809-13.25-8.71%
1 Year128.65157.00109.16142.177,782,26310.267.98%
3 Years141.08157.00109.16136.957,145,609-2.17-1.54%
5 Years100.17157.0094.28129.836,661,91238.7438.67%

Johnson and Johnson Description

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.